• Esprinet’s nine-month 2026 adjusted EBITDA jumped 31% year over year to EUR 49 million.
• Revenue for the same period rose 10% year over year to EUR 3.19 billion.
• The group reaffirmed its 2026 adjusted EBITDA guidance of EUR 77 million to EUR 82 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Esprinet S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 0533-25-2026_TELEBORSA.pdf), on November 11, 2026, and is solely responsible for the information contained therein.